"Carcinoma, Endometrioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
- Carcinoma, Endometrioid
- Carcinomas, Endometrioid
- Endometrioid Carcinoma
- Endometrioid Carcinomas
- Adenocarcinoma, Endometrioid
- Adenocarcinomas, Endometrioid
- Endometrioid Adenocarcinomas
- Endometrioid Adenocarcinoma
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Endometrioid".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Neoplasms by Site [C04.588]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Uterine Neoplasms [C04.588.945.418.948]
- Endometrial Neoplasms [C04.588.945.418.948.585]
- Carcinoma, Endometrioid [C04.588.945.418.948.585.124]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Genital Diseases, Female [C13.351.500]
- Adnexal Diseases [C13.351.500.056]
- Ovarian Diseases [C13.351.500.056.630]
- Ovarian Neoplasms [C13.351.500.056.630.705]
- Carcinoma, Endometrioid [C13.351.500.056.630.705.331]
- Urogenital Neoplasms [C13.351.937]
- Genital Neoplasms, Female [C13.351.937.418]
- Ovarian Neoplasms [C13.351.937.418.685]
- Carcinoma, Endometrioid [C13.351.937.418.685.331]
- Uterine Neoplasms [C13.351.937.418.875]
- Endometrial Neoplasms [C13.351.937.418.875.200]
- Carcinoma, Endometrioid [C13.351.937.418.875.200.124]
- Endocrine System Diseases [C19]
- Gonadal Disorders [C19.391]
- Ovarian Diseases [C19.391.630]
- Ovarian Neoplasms [C19.391.630.705]
- Carcinoma, Endometrioid [C19.391.630.705.331]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Endometrioid".
This graph shows the total number of publications written about "Carcinoma, Endometrioid" by people in this website by year, and whether "Carcinoma, Endometrioid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Endometrioid" by people in Profiles.
Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. Int J Gynecol Cancer. 2022 07 04; 32(7):869-874.
The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament). Histopathology. 2022 Sep; 81(3):280-296.
Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study. Int J Gynecol Pathol. 2023 Jan 01; 42(1):26-34.
Low grade endometrioid endometrial cancer: complexities beyond p53abn. Int J Gynecol Cancer. 2021 09; 31(9):1312.
Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report. Int J Gynecol Pathol. 2020 May; 39(3):233-237.
Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors. Gynecol Oncol. 2019 12; 155(3):429-435.
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019 10; 155(1):39-50.
Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma. Mod Pathol. 2019 10; 32(10):1508-1520.
Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas. Am J Surg Pathol. 2019 02; 43(2):235-243.
Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes. Mod Pathol. 2019 03; 32(3):396-404.